Literature DB >> 11243068

Paediatric inpatient morbidity patterns and drug usage in a teaching hospital serving an underdeveloped area.

V R Dharnidharka1, P Kandoth.   

Abstract

Morbidity patterns and drug usage in hospitalized children in a developing area were prospectively studied. The study group consisted of 347 children (age 0-12 yrs) representing all admissions to a paediatric unit over a six month period. Respiratory tract diseases (30.5%) and infectious diseases (26.1%) were the most common reasons for hospitalization. Tuberculosis was the most common infectious disease seen among the hospitalized children. Antimicrobials (60.8%), iron preparations (45.5%), vitamins (43.2%) and antipyretics (29.9%) were the most frequently prescribed groups of drugs. Ampicillin was the most commonly used antimicrobial. Adverse drug reactions were seen in 1.7% of the children. The overall mortality was 9.2%. The mean length of stay was 7.9 days and the mean number of drugs used was 3.4 per patient. More than 4 drugs were prescribed in 54.4% of children. Approximately two thirds received parenteral therapy.

Entities:  

Mesh:

Year:  1999        PMID: 11243068

Source DB:  PubMed          Journal:  Indian J Public Health        ISSN: 0019-557X


  4 in total

1.  Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values.

Authors:  Steffen Haffner; Nicoletta von Laue; Stefan Wirth; Petra A Thürmann
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Profile of patients attending pediatric emergency service at Chandigarh.

Authors:  Manju Salaria; Sunit C Singhi
Journal:  Indian J Pediatr       Date:  2003-08       Impact factor: 1.967

3.  Directly observed treatment for tuberculosis.

Authors:  V K Arora; Rajnish Gupta
Journal:  Indian J Pediatr       Date:  2003-11       Impact factor: 1.967

4.  Burden of hospitalized pediatric morbidity and utilization of beds in a tertiary care hospital of kolkata, India.

Authors:  Rabindra Nath Roy; Prabha Shrivastava; Dilip Kumar Das; Indranil Saha; Aditya Prasad Sarkar
Journal:  Indian J Community Med       Date:  2012-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.